首頁 > 市場調查報告書 > 製藥

生物製劑

質粒 DNA 製造市場：按產品類型、等級、應用、製造類型、發展階段、地區 - 規模、份額、展望、機會分析，2022-2030 年

市場調查報告書

商品編碼

1213972

質粒 DNA 製造市場：按產品類型、等級、應用、製造類型、發展階段、地區 - 規模、份額、展望、機會分析，2022-2030 年

Plasmid DNA Manufacturing Market, By Product Type, By Grade, By Application, By Manufacturing Type, By Development Phase, By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2023年01月18日 | 出版商:

Coherent Market Insights | 英文 266 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

質粒DNA是一種環狀雙鏈DNA，存在於細菌細胞質中，獨立於細菌染色體進行複製。質粒是細胞內的一個小的額外染色體 DNA 分子，它與染色體 DNA 物理分離並能夠獨立複製。質粒最常見於細菌中，作為小的、環狀的、雙鏈 DNA 分子存在。然而，質粒也可以存在於古細菌和真核生物中。

每個質粒都有自己的 "複製起點" 。這是一段由宿主細菌可靠地複製（拷貝）的 DNA。正因為如此，質粒可以獨立於細菌染色體進行自我複製，並且細菌細胞內可以有許多（有時數百個）質粒拷貝。

市場動態

為了滿足合適的產品及其產量要求，對現有製造技術進行創新的需求預計將為市場上的主要參與者提供巨大的增長機會。例如，2021 年 3 月，總部位於蓋恩斯維爾的生物技術公司 Evolugate, LLC 證明其專有技術可用於提高質粒 DNA 製造的吞吐量。

預計市場參與者通過收購來擴大其產品組合等無機策略將推動預測期內的市場增長。例如，2022 年 1 月，Aldebron 宣佈收購 Nature Technology Corporation (NTC)，後者是一家開髮用於細胞和基因治療領域的創新和專有質粒構建體和製造解決方案的公司。 NTC 基於核酸的技術包括 Nanoplasmid，這是一種專有的載體結構，可提高質粒和生物製劑的安全性和性能。

這項研究的主要特點

本報告對全球質粒 DNA 製造市場進行了深入分析，提供了以 2021 年為基準年的預測期（2022-2030 年）的市場規模和復合年增長率 (CAGR%) 增長情況。
它揭示了不同細分市場的潛在收入機會，並為該市場概述了一個有吸引力的投資建議矩陣。
它還提供重要的見解，例如市場驅動因素、制約因素、機會、新產品發佈或批准、市場趨勢、區域前景以及主要參與者採用的競爭戰略。
它根據以下參數介紹了全球質粒 DNA 製造市場的主要參與者 - 公司亮點、產品組合、主要亮點、財務業績、作為本研究的一部分涵蓋的關鍵戰略公司包括 Cobra Biologics 和 Pharmaceutical Services（Charles River Laboratories)、VGXI, Inc.、Aldevron (Danaher)、Kaneka Corporation、Nature Technology、PlasmidFactory GmbH & Co. KG、Cell and Gene Therapy Catapult、LakePharma, Inc.、MeiraGTx Limited、Eurofins Genomics、Vigene Biosciences、Luminous BioSciences ( LBS), LLC, GenScript, GENEWIZ, Creative Biogene, Akron Biotech, Biomay, JAFRAL Ltd., WuXi Biologics, GeneImmune Biotechnology Corp., Lonza, Greenpak Biotech Ltd., Luina Bio (AcuraBio), Ajinomoto Bio-Pharma, Synbio Technologies, Genopis Inc.、Altogen Biosystems、Puresyn, Inc.、Cepham Life Sciences、Catalent, Inc.、Biomiga、Waisman Biomanufacturing
這份報告中的見解應該能夠讓企業營銷人員和管理人員就未來的產品發佈、類型升級、市場擴張和營銷策略做出明智的決策。.
《全球質粒 DNA 製造市場》報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者可以通過用於分析全球質粒 DNA 製造市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

調查目的
先決條件
縮寫說明

第二章市場展望

報告內容
- 市場定義和範圍
執行摘要
- 按產品類型劃分的市場概況
- 市場概況：按等級
- 市場概況：按應用分類
- 按製造類型分類的快照
- 市場概況：按發展階段
- 市場概況：按地區
連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

市場動態
- 司機
- 約束因素
- 市場吸引力分析
- 市場機會
產品發佈
合併、收購、聯合研究
監管準則和合規性
主要發展狀況
害蟲分析
技術
對 PORTER 的分析
定價分析 (2021)
針對質粒 DNA 疫苗開發的指南
基因組效價

第 4 章全球質粒 DNA 製造市場-冠狀病毒 (COVID-19) 大流行的影響

經濟影響
COVID-19 的流行病學特徵
對供需的影響

第 5 章按產品類型分列的全球質粒 DNA 製造市場，2017-2030

病毒載體
質粒DNA
非病毒式

第 6 章按等級分列的全球質粒 DNA 製造市場，2017-2030

GMP 等級
研發級別
臨床等級

第 7 章質粒 DNA 製造的全球市場，按應用，2017-2030（百萬美元

DNA疫苗
基因治療
免疫療法
RNA 疫苗
其他

第 8 章質粒 DNA 製造全球市場，按製造類型，2017-2030（百萬美元

外包
內部製造

第 9 章全球質粒 DNA 製造市場，按發展階段，2017-2030，（百萬美元）

臨床前藥物
臨床藥物
已上市藥物

第 10 章全球質粒 DNA 製造市場，按地區劃分，2017-2030

北美
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲地區
歐洲
英國
德國
意大利
法國
西班牙
俄羅斯
其他歐洲
亞太地區
中國
印度
日本
東盟
澳大利亞
韓國
其他亞太地區
中東
海灣合作委員會
以色列
其他中東地區
非洲
北非
中非
南非

第11章競爭格局

Cobra Biologics and Pharmaceutical Services（Charles River Laboratories）.
VGXI, Inc.
Aldevron（Danaher）
Kaneka Corporation
Nature Technology
PlasmidFactory GmbH & Co. KG
Cell and Gene Therapy Catapult
LakePharma, Inc.
MeiraGTx Limited
Eurofins Genomics
Vigene Biosciences
Luminous BioSciences（LBS）, LLC
GenScript
GENEWIZ
Creative Biogene
Akron Biotech
Biomay
JAFRAL Ltd.
WuXi Biologics
GeneImmune Biotechnology Corp.
Lonza
Greenpak Biotech Ltd.
Luina Bio（AcuraBio）
Ajinomoto Bio-Pharma
Synbio Technologies
Genopis Inc.
Altogen Biosystems
Puresyn, Inc.
Cepham Life Sciences
Catalent, Inc.
Biomiga
Waisman Biomanufacturing

第12章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI2593

Circular double-stranded DNA present in the cytoplasm of a bacteria that replicate independently from the bacterial chromosome is called a plasmid DNA. Plasmids are small extra chromosomal DNA molecules within cells that are physically separated from the chromosomal DNA and capable of independent replication. They are most commonly found as small circular double-stranded DNA molecules in bacteria. However, plasmids can be present in archaea and eukaryotes.

Each plasmid has its own "origin of replication". This is a stretch of DNA that ensures it is replicated (copied) by the host bacteria. Because of this, plasmids can copy themselves independently of the bacterial chromosome, and there can be many, possibly hundreds, copies of the plasmid within the bacterial cell.

Market Dynamics

Demand for innovation in existing manufacturing technologies, in order to meet the requirement of appropriate products and its volume is expected to provide immense growth opportunities for key players in the market. For instance, in March 2021, Evolugate, LLC, a Gainesville-based biotech company, has demonstrated that its proprietary technology can be used to improve the throughput of plasmid DNA manufacturing.

The increasing inorganic strategies such as acquisition by the key players in the market to expand product portfolio is expected to drive the market growth over the forecast period. For instance, In January 2022, Aldevron announced the acquisition of Nature Technology Corporation (NTC), a developer of innovative and proprietary plasmid constructs and manufacturing solutions that are used in the field of cell and gene therapy. NTC's nucleic acid-based technologies include Nanoplasmid, a proprietary vector construct that improves the safety and performance of plasmids and biologics.

Key features of the study:

This report provides in-depth analysis of the global plasmid DNA manufacturing market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global plasmid DNA manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Cobra Biologics and Pharmaceutical Services (Charles River Laboratories), VGXI, Inc., Aldevron (Danaher), Kaneka Corporation, Nature Technology, PlasmidFactory GmbH & Co. KG, Cell and Gene Therapy Catapult, LakePharma, Inc., MeiraGTx Limited, Eurofins Genomics, Vigene Biosciences, Luminous BioSciences (LBS), LLC, GenScript, GENEWIZ, Creative Biogene, Akron Biotech, Biomay, JAFRAL Ltd., WuXi Biologics, GeneImmune Biotechnology Corp., Lonza, Greenpak Biotech Ltd., Luina Bio (AcuraBio), Ajinomoto Bio-Pharma, Synbio Technologies, Genopis Inc., Altogen Biosystems, Puresyn, Inc., Cepham Life Sciences, Catalent, Inc., Biomiga, Waisman Biomanufacturing
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global plasmid DNA manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global plasmid DNA manufacturing market

Detailed Segmentation:

Global Plasmid DNA Manufacturing Market, By Product Type:
- Viral Vectors
  - Retroviral
  - Adenoviral
  - Lentiviral
  - Adeno Associates
  - Others
- Plasmid DNA
  - mRNA
  - Others
- Non-viral
  - Lipid/Polymer
  - Electroporation
  - Nanoparticles
  - Others
Global Plasmid DNA Manufacturing Market, By Grade:
- GMP Grade
- R&D Grade
- Clinical Grade
Global Plasmid DNA Manufacturing Market By Application:
- DNA Vaccines
- Gene Therapy
- Immunotherapy
- RNA Vaccines
- Others
Global Plasmid DNA Manufacturing Market By Manufacturing Type:
- Outsourcing
- In-house Manufacturing
Global Plasmid DNA Manufacturing Market By Development Phase:
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
Global Plasmid DNA Manufacturing Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country:
- India
- China
- Japan
- Australia
- ASEAN
- South Korea
- Rest of Middle East
- Middle East
  - By Country:
- GCC
- Israel
- Japan
- Africa
  - By Country/Region:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Cobra Biologics and Pharmaceutical Services (Charles River Laboratories)*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- VGXI, Inc.
- Aldevron (Danaher)
- Kaneka Corporation
- Nature Technology
- PlasmidFactory GmbH & Co. KG
- Cell and Gene Therapy Catapult
- LakePharma, Inc.
- MeiraGTx Limited
- Eurofins Genomics
- Vigene Biosciences
- Luminous BioSciences (LBS), LLC
- GenScript
- GENEWIZ
- Creative Biogene
- Akron Biotech
- Biomay
- JAFRAL Ltd.
- WuXi Biologics
- GeneImmune Biotechnology Corp.
- Lonza
- Greenpak Biotech Ltd.
- Luina Bio (AcuraBio)
- Ajinomoto Bio-Pharma,
- Synbio Technologies, Genopis Inc.
- Altogen Biosystems, Puresyn, Inc.
- Cepham Life Sciences, Catalent, Inc.
- Biomiga
- Waisman Biomanufacturing

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Grade
- Market Snapshot, By Application
- Market Snapshot, By Manufacturing Type
- Market Snapshot, By Development Phase
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Product Launches
Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
Technology Landscape
PORTER's Analysis
Pricing Analysis (2021)
Guidelines Specific for the Development of Plasmid DNA Vaccines
Genomic Titer

4. Global Plasmid DNA Manufacturing Market- Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Plasmid DNA Manufacturing Market, By Product Type, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Viral Vectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Retroviral
- Adenoviral
- Lentiviral
- Adeno Associates
- Others
Plasmid DNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- mRNA
- Others
Non-viral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Lipid/Polymer
- Electroporation
- Nanoparticles
- Others

6. Global Plasmid DNA Manufacturing Market, By Grade, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
GMP Grade
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
R&D Grade
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Clinical Grade
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Plasmid DNA Manufacturing Market, By Application, 2017 - 2030, (US$ Million

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segments Trends
DNA Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
RNA Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Plasmid DNA Manufacturing Market, By Manufacturing Type, 2017 - 2030, (US$ Million

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segments Trends
Outsourcing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
In-house Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Plasmid DNA Manufacturing Market, By Development Phase, 2017 - 2030, (US$ Million

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segments Trends
Pre-Clinical Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Clinical Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Marketed Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

10. Global Plasmid DNA Manufacturing Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Grade, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Grade, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2017 - 2030, (US$ Million
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Grade, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2017 - 2030, (US$ Million
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Grade, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2017 - 2030, (US$ Million
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Grade, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2017 - 2030, (US$ Million
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Grade, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2017 - 2030, (US$ Million
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa

11. Competitive Landscape

Cobra Biologics and Pharmaceutical Services (Charles River Laboratories).*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
VGXI, Inc.
Aldevron (Danaher)
Kaneka Corporation
Nature Technology
PlasmidFactory GmbH & Co. KG
Cell and Gene Therapy Catapult
LakePharma, Inc.
MeiraGTx Limited
Eurofins Genomics
Vigene Biosciences
Luminous BioSciences (LBS), LLC
GenScript
GENEWIZ
Creative Biogene
Akron Biotech
Biomay
JAFRAL Ltd.
WuXi Biologics
GeneImmune Biotechnology Corp.
Lonza
Greenpak Biotech Ltd.
Luina Bio (AcuraBio)
Ajinomoto Bio-Pharma
Synbio Technologies
Genopis Inc.
Altogen Biosystems
Puresyn, Inc.
Cepham Life Sciences
Catalent, Inc.
Biomiga
Waisman Biomanufacturing